Oxurion

Foundation date

30/05/2006

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

Oxurion is dedicated to developing and commercializing new pharmacologic ophthalmic treatments that address important unmet clinical needs. By meeting this goal Oxurion intends to help patients around the world with a new or better treatment for their condition.

Upcoming events

Latest news

  • BIO INX Complements Advisory Board with Distinguished Industry Leaders

    1 day ago

  • Innovating today, creating tomorrow: the VIB Bio-Incubator

    1 day ago

  • BioLizard Appoints Matthew Hall as Director of Business Development

    1 day ago